Skip to main content
. Author manuscript; available in PMC: 2017 Mar 6.
Published in final edited form as: J Hum Hypertens. 2016 May 12;30(12):731–736. doi: 10.1038/jhh.2016.27

Table 4.

Prevalence ratios for nocturnal hypertension, isolated nocturnal hypertension, and non-dipping pattern associated with diabetes among Jackson Heart Study participants taking antihypertensive medication.

No Diabetes Diabetes
Nocturnal Hypertension N=371 N=196
Prevalence, n (%) 207 (55.8%) 143 (73.0%)
Prevalence ratio (95% CI)
 Model 1 1 (ref) 1.29 (1.14–1.46)
 Model 2 1 (ref) 1.29 (1.14–1.46)
 Model 3 1 (ref) 1.28 (1.12–1.45)
 Model 4 1 (ref) 1.07 (0.95–1.21)
Isolated Nocturnal Hypertension N=223 N=100
Prevalence, n (%) 81 (36.3%) 52 (52.0%)
Prevalence ratio (95% CI)
 Model 1 1 (ref) 1.41 (1.10–1.82)
 Model 2 1 (ref) 1.36 (1.05–1.78)
 Model 3 1 (ref) 1.27 (0.97–1.66)
 Model 4 1 (ref) 1.08 (0.83–1.40)
Non-dipping Pattern N=371 N=196
Prevalence, n (%) 252 (67.9%) 143 (73.0%)
Prevalence ratio (95% CI)
 Model 1 1 (ref) 1.07 (0.96–1.19)
 Model 2 1 (ref) 1.03 (0.93–1.15)
 Model 3 1 (ref) 1.03 (0.92–1.15)
 Model 4 1 (ref) 1.07 (0.95–1.20)

CI: confidence interval

See Table 1 for the definitions of nocturnal hypertension, isolated nocturnal hypertension and non-dipping pattern.

Analyses of isolated nocturnal hypertension restricted to participants without elevated daytime hypertension.

Model 1 is adjusted for age and sex.

Model 2 is adjusted for variables in Model 1 + education, marital status, current smoking, physical activity, BMI.

Model 3 is adjusted for variables in Model 2 + history of stroke, history of myocardial infarction, total and HDL-cholesterol, and taking ≥ 3 classes of antihypertensive medications.

Model 4 is adjusted for variables in Model 3 + daytime SBP.